Jing Zhu is the Vice President, Head of Process Development, at ReciBioPharm, overseeing ATMP technology platform establishment and development activities. He has 15+ years of experience in process and analytical development, chemistry manufacturing controls (CMC) program management and management of CRDMO within the pharmaceutical industry. Prior to joining ReciBioParm, Jing has been at various leadership roles crossing biotech pharma and solution companies leading nucleic acid and viral vector development and production for cell & gene therapy applications.